Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Medtronic-Sequoia China Fund Leads Series B Round in Forerunner Medical

publication date: Feb 13, 2017
The Medtronic-Sequoia China Healthcare Technology Venture Investment Fund led a Series B round in Forerunner Medical (Shanghai) Co., Ltd. Existing investors, Sequoia and WuXi Healthcare Ventures, also participated in the series B round. At the same time, Forerunner Medical has completed the acquisition of MedSphere Shanghai, a subsidiary company of MedSphere International, a minimally invasive medical devices and surgical products maker. No financial details were announced for the two transactions. More details.... 

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital